Letrozole is a drug approved for use only in postmenopausal women with breast cancer. But there is evidence some doctors have prescribed it as a fertility treatment because it suppresses estrogen and can promote ovulation. It is marketed under the name Femara.
The manufacturer of a breast cancer drug, letrozole, has warned fertility doctors that it has been associated with birth defects, a caution prompted by reports that the drug was being used to help a woman become pregnant.
Swiss drug manufacturer Novartis sent letters to fertility doctors worldwide to reiterate a warning that the drug should not be given to women who may be pregnant.
The U.S. label on the drug already warned that it has been associated with birth defects, but doctors continued to utilize Femara for an off-label use.
If you or a loved one has taken Femara and experienced serious side effects, contact us to determine whether you have a personal injury claim.